Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?

Saved in:
Bibliographic Details
Published in:Pharmacological research 2021-12, Vol.174, p.105878-105878, Article 105878
Main Authors: Zhao, Li-Min, Huang, Jia-Nan, Qiu, Mei, Chang, Rong
Format: Article
Language:English
Subjects:
Cardiovascular
Cardiovascular Diseases
Death
Diabetes Mellitus, Type 2 - complications
Dipeptidyl-Peptidase IV Inhibitors
DPP4i
Humans
Secondary Prevention
SGLT2i
Sodium-Glucose Transporter 2 Inhibitors
Type 2 diabetes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1043-6618
1096-1186
DOI:10.1016/j.phrs.2021.105878